Cystatin C in critically ill patients treated with continuous venovenous hemofiltration
- 3 October 2006
- journal article
- Published by Wiley in Hemodialysis International
- Vol. 10 (S2) , S33-S37
- https://doi.org/10.1111/j.1542-4758.2006.00115.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studiesNephrology Dialysis Transplantation, 2005
- Cystatin C as a Marker of Residual Renal Function during Continuous HemodiafiltrationKidney and Blood Pressure Research, 2004
- Could Plasma Cystatin C Be Useful as a Marker of Hemodialysis Low Molecular Weight Proteins Removal?Nephron Clinical Practice, 2004
- Time course of low molecular weight proteins in the early kidney transplantation period--influence of corticosteroidsNephrology Dialysis Transplantation, 2004
- Is Cystatin C a Marker of Glomerular Filtration Rate in Thyroid Dysfunction?Clinical Chemistry, 2003
- Impact of thyroid dysfunction on serum cystatin CKidney International, 2003
- Cystatin C, β2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinineJournal of Pharmaceutical and Biomedical Analysis, 2001
- Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adultsScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Renal handling of radiolabelled human cystatin C in the ratScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cellsScandinavian Journal of Clinical and Laboratory Investigation, 1995